The MarketWatch News Department was not involved in the creation of this content. -- Adolescents in a long-term, open-label extension study receiving a twice-daily low dose of repinatrabit achieved ...
Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals' genetic ancestry. PKU causes an amino acid—called ...
Zacks Investment Research on MSN
BEAM stock gains 5% as FDA clears BEAM-304 IND for phenylketonuria
Shares of Beam Therapeutics BEAM rose 5% on Thursday after the FDA cleared the investigational new drug (IND) application for BEAM-304, the company’s investigational gene-editing therapy for the ...
(StatePoint) Imbalances in mood, learning, memory and motivation could be a result of PKU, which is short for phenylketonuria. Also known as PAH deficiency, this is a rare genetic condition that ...
Phenylketonuria (PKU) is a hereditary metabolic disorder caused by deficient activity of phenylalanine hydroxylase, leading to accumulation of the amino acid phenylalanine to neurotoxic levels. Early ...
Phenylketonuria is an autosomal recessive disorder of amino acid metabolism arising from pathogenic variants in the gene encoding phenylalanine hydroxylase. Loss or reduction of enzyme function ...
Bone mineral density is generally lower in PKU compared to the general population—yet still in the normal range. Here, Stephanie Sacharow, MD, a medical biochemical geneticist based in Boston, MA ...
Within a few days after birth, babies around the world undergo a quick needle prick to the heel. The blood drop that results is used to detect as many as 50 genetic disorders so that, if found, they ...
FOX 32 Chicago on MSN
One in 25,000 people has PKU. This suburban Chicago mom—and her daughter—are among them
A Crystal Lake woman who teaches special education in Chicago Public Schools has managed phenylketonuria, a rare genetic ...
PHILADELPHIA— Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals’ genetic ancestry. PKU causes an amino ...
Adolescents in a long-term, open-label extension study receiving a twice-daily low dose of repinatrabit achieved clinically meaningful reductions in blood Phe levels at month one of the open-label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results